Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

MUN/5VA stock hub

MUN/5VA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

MUN/5VAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
6.5B
Munich Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
MUN/5VA
In the news

Latest news · MUN/5VA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-30.6
P25 n/aP50 n/aP75 n/a
ROIC-21.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All MUN/5VA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
142
Groups with data
11
Currency
USD
Showing 142 of 142 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

17
MetricValue
Country
United States
Country code
DE
Employees
507
Employees Change
93%
Employees Change Percent
22.46
Enterprise value
EUR 5.1B
Exchange
Munich Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 6.5B
Price
EUR 43.2
Price currency
EUR
Sic
2836
Symbol
mun/5VA
Website
https://vaxcyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-12.62%
EV Earnings
-6.24x
EV/FCF
-7.25x
FCF yield
-10.87%
P/B ratio
2.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

8
MetricValue
Net Income
EUR -820.9M
Profit Per Employee
EUR -1.6M
ROA
-20.23
Roa5y
-19.26
ROCE
-35.05
ROE
-30.55
Roe5y
-30.11
ROIC
-21.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

3
MetricValue
Cagr1y
40.29%
Cagr3y
-0.76%
Cagr5y
23.73%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
EUR 2.9B
Cash
EUR 1.5B
Current Assets
EUR 1.5B
Current Liabilities
EUR 205.3M
Debt
EUR 100.9M
Debt Equity
EUR 0.04
Debt FCF
EUR -0.14
Equity
EUR 2.6B
Liabilities
EUR 305.5M
Long Term Assets
EUR 1.4B
Long Term Liabilities
EUR 100.3M
Net Cash
EUR 1.4B
Net Cash By Market Cap
EUR 21.62
Net Cash Growth
2.29%
Net Debt Equity
EUR -0.54
Tangible Book Value
EUR 2.6B
Tangible Book Value Per Share
EUR 18.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
7.49
Net Working Capital
EUR -138.5M
Quick ratio
7.18
Working Capital
EUR 1.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-7.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
40.26%
200-day SMA
29.53
3Y total return
-2.26%
50-day SMA
47.44
50-day SMA vs 200-day SMA
50over200
5Y total return
189.93%
All Time High
100
All Time High Change
-56.8%
All Time High Date
2024-09-06
All Time Low
13.6
All Time Low Change
217.65%
All Time Low Date
2021-05-11
ATR
5.79
Ch YTD
9.65
High
48
High52
51.5
High52 Date
2026-03-09
High52ch
-16.12%
Low
43.2
Low52
25.8
Low52 Date
2025-08-12
Low52ch
67.44%
Ma50ch
-8.94%
Price vs 200-day SMA
46.29%
RSI
48.06
RSI Monthly
49.98
RSI Weekly
50.29
Sharpe ratio
0.87x
Sortino ratio
1.79
Total Return
-7.07%
Tr YTD
9.65
Tr1m
-16.12%
Tr1w
-14.46%
Tr3m
8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
EUR -944.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
132,711,358%
Shares Insiders
0.67%
Shares Institutions
98.59%
Shares Qo Q
2.25%
Shares Yo Y
7.07%
Short Ratio
10.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

46
MetricValue
Adjusted FCF
EUR -833.6M
Average Volume
154.4x
Bv Per Share
18.01
CAPEX
EUR -39M
Ch1m
-16.12
Ch1w
-14.46
Ch1y
40.26
Ch3m
8
Ch3y
-2.26
Ch5y
189.9
Ch6m
24.86
Change
-14.46%
Change From Open
-10
Close
50.5
Days Gap
-4.95
Depreciation Amortization
13,895,553.3
Dollar Volume
7,041.6
Earnings Date
2026-05-14
EBIT
EUR -944.3M
EBITDA
EUR -930M
EPS
EUR -5.99
F Score
1
FCF
EUR -706.8M
FCF EV Yield
-13.79x
Financing CF
522,841,397
Fiscal Year End
December
Founded
2,013
Investing CF
69,927,797
Is Primary Listing
0
Last Earnings Date
2026-02-24
Last Report Date
2026-03-31
Ma150
28.44
Ma150ch
51.93%
Ma20
47.92
Ma20ch
-9.84%
Net CF
-74,466,378
Next Earnings Date
2026-05-14
Open
48
Position In Range
0
Ppne
316,966,499.7
Price Date
2026-05-07
Ptbv Ratio
2.5
Relative Volume
1.06x
Share Based Comp
126,794,056
Tr6m
24.86%
Volume
163
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does MUN/5VA pay a dividend?

Capital-return profile for this ticker.

Performance

MUN/5VA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+40.3%
S&P 500 1Y: n/a
3Y total return
-2.3%
S&P 500 3Y: n/a
5Y total return
+189.9%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns MUN/5VA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+98.6%
Share of float held by funds and institutions
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
10.7 days to cover
Y/Y dilution
+7.1%
Negative means the company is buying back shares.
Technical

MUN/5VA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
48.1
Neutral momentum band
Price vs 200-day MA
+46.3%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.87
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About MUN/5VA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current mun/5VA stock rating?

mun/5VA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full mun/5VA analysis?

The full report lives at /stocks/mun/5VA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for mun/5VA?

The latest report frames mun/5VA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the mun/5VA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.